Genetic Testing 101 Part A

Introduction

Genetic Testing 101 Part A

Course Format

Self-Guided

Release Date

September 03, 2020

Expiration Date

September 03, 2026

Program Description

The MDS Genetic Testing 101 (Part A) course will provide a comprehensive overview of genetic testing.

Accreditation and Credit Designation

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.

FACULTY DISCLOSURE

All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available HERE. All relevant financial relationships have been mitigated in advance of this program.

SATISFACTORY COMPLETION

Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.

METHOD OF PARTICIPATION

Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.

CONTENT VALIDITY STATEMENT

All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.

Contact Us

MDS Education
education@movementdisorders.org

Course Overview

FACULTY

Henry Houlden - UCL Institute of Neurology, London, United Kingdom

Viorica Chelban, MD - University College London, London, United Kingdom

LEARNING OBJECTIVES

Upon completion of this activity, learners will be able to:

1. Describe what genetic testing is, how it can be obtained, how results can be interpreted, and the limitations of the various available methods.

2. Recognize when and what type of genetic testing should be performed for a patient with a movement disorder.

3. Discuss the important ethical issues and principles involved in genetic testing and counseling.

INTENDED AUDIENCE

This activity is intended for students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have limited to no movement disorder experience.

HARDWARE AND SOFTWARE REQUIREMENTS

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.

2. Compatible with Windows PC and MAC (256 MB of RAM or higher).

3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.

4. Adobe Flash Player 12.0 (or higher).

5. Adobe Reader to print certificate.